IP Library Granted Patent US 7,738,952
Granted Patent B2
US 7,738,952 · App. 11/060,643 · Granted Jun 15, 2010

Treatment of conditions through modulation of the autonomic nervous system

Assignee: Palo Alto Investors
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,738,952
App. No.
11/060,643
Granted
Jun 15, 2010
Kind
B2
Abstract

Methods are provided for treating a subject for a condition by modulating at least a portion of the subject's autonomic nervous system. In accordance with certain embodiments of the subject methods, at least a portion of a subject's autonomic nervous system is electrically or pharmacologically modulated in a manner that is effective to treat the subject for the condition. The subject methods find use in the treatment of a variety of different conditions, where such conditions include various disease conditions. Also provided are systems and kits for use in practicing the subject methods.

Claims (5)

1. A method of treating a subject for a condition comprising electrically modulating at least a portion of said subject's autonomic nervous system to increase the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for said condition, wherein said condition is a neurodegenerative condition chosen from the group of Alzheimer's Disease, Pick's Disease, Parkinson's Disease, dementia, delirium, and amyotrophic lateral sclerosis.

2. A method of treating a subject for a condition comprising electrically modulating at least a portion of said subject's autonomic nervous system to increase the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for said condition, wherein said condition is a lymphoproliferative condition chosen from the group of: lymphoma, lymphoproliferative disease, Hodgkin's disease, and inflammatory pseudotumor of the liver.

3. A method of treating a subject for a condition comprising electrically modulating at least a portion of said subject's autonomic nervous system to increase the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for said condition, wherein said condition is a gastrointestinal condition chosen from the group of: hepatitis, xerostomia, bowel mobility, peptic ulcer disease, constipation, ileus, irritable bowel syndrome, post-operative bowel dysmotility, inflammatory bowel disease, typhilitis, cholelithiasis, cholestasis, fecal incontinence, and cyclic vomiting syndrome.

4. A method of treating a subject for a condition comprising electrically modulating at least a portion of said subject's autonomic nervous system to increase the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for said condition, wherein said condition is a skin condition chosen from the group of: wrinkles, cutaneous vasculitis, rash; and psoriasis.

5. A method of treating a subject for a condition comprising electrically modulating at least a portion of said subject's autonomic nervous system to increase the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for said condition, wherein said condition is a Th-2 dominant condition chosen from the group of: typhilitis, osteoporosis, lymphoma, myasthenia gravis, and lupus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2005
From: YUN, ANTHONY JOONKYOO; LEE, PATRICK YUARN-BOR
To: PALO ALTO INVESTORS
Reel/Frame 016089/0173 →
Continuity (7)
Continuation In Part 1087136600 · Jun 18, 2004
Continuation In Part 1066136800 · Sep 12, 2003
Provisional Application 6054795500 · Feb 25, 2004
Provisional Application 6047707000 · Jun 9, 2003
Provisional Application 6048259300 · Jun 24, 2003
Provisional Application 6049426000 · Aug 11, 2003
Related Publication 20050240241A1 · Oct 27, 2005